[go: up one dir, main page]

MX2009004203A - Combinaciones de paracetamol/ibuprofeno y metodo para su uso. - Google Patents

Combinaciones de paracetamol/ibuprofeno y metodo para su uso.

Info

Publication number
MX2009004203A
MX2009004203A MX2009004203A MX2009004203A MX2009004203A MX 2009004203 A MX2009004203 A MX 2009004203A MX 2009004203 A MX2009004203 A MX 2009004203A MX 2009004203 A MX2009004203 A MX 2009004203A MX 2009004203 A MX2009004203 A MX 2009004203A
Authority
MX
Mexico
Prior art keywords
acetaminophen
ibuprofen
parts
dosage form
ibuprofen combinations
Prior art date
Application number
MX2009004203A
Other languages
English (en)
Inventor
Jim Swann
Peter Cummins
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of MX2009004203A publication Critical patent/MX2009004203A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona una forma de dosificación farmacéutica que comprende un agente antiinflamatorio no esteroideo y acetaminofeno, y métodos para su uso; en una modalidad, la forma de dosificación está comprendida por ibuprofeno y acetaminofeno como los únicos agentes farmacéuticamente efectivos, en donde el ibuprofeno y acetaminofeno tienen una relación en peso de alrededor de 12 partes: a aproximadamente 88 partes.
MX2009004203A 2006-10-20 2007-10-17 Combinaciones de paracetamol/ibuprofeno y metodo para su uso. MX2009004203A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85350906P 2006-10-20 2006-10-20
PCT/US2007/081589 WO2008051759A1 (en) 2006-10-20 2007-10-17 Acetaminophen / ibuprofen combinations

Publications (1)

Publication Number Publication Date
MX2009004203A true MX2009004203A (es) 2009-07-02

Family

ID=39092896

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004203A MX2009004203A (es) 2006-10-20 2007-10-17 Combinaciones de paracetamol/ibuprofeno y metodo para su uso.

Country Status (12)

Country Link
US (2) US8580855B2 (es)
EP (2) EP3292866B1 (es)
JP (1) JP5389656B2 (es)
KR (1) KR20090094076A (es)
CN (1) CN101563074B (es)
AU (1) AU2007309281B2 (es)
BR (1) BRPI0718171A2 (es)
CA (1) CA2666582C (es)
ES (1) ES2651444T3 (es)
MX (1) MX2009004203A (es)
RU (1) RU2465897C2 (es)
WO (1) WO2008051759A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012590A1 (en) * 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
MX2010007358A (es) * 2008-01-03 2011-05-25 Wockhardt Research Center Suspension farmaceutica oral que comprende paracetamol e ibuprofen.
US20120064159A1 (en) * 2009-05-28 2012-03-15 Aptapharma, Inc. Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
UA102916C2 (uk) * 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
JP5740896B2 (ja) * 2009-10-27 2015-07-01 ライオン株式会社 解熱鎮痛組成物
CA2783569C (en) * 2009-12-15 2017-07-04 Teikoku Seiyaku Co., Ltd. Transdermally absorbable preparation containing basic anti-inflammatory analgesic
US20180264013A1 (en) * 2010-07-08 2018-09-20 Wellesley Pharmaceuticals, Llc Composition and methods for treating sleep disorders
US20130323288A1 (en) * 2010-07-08 2013-12-05 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
US10010514B2 (en) * 2010-07-08 2018-07-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
JP2013541583A (ja) 2010-11-04 2013-11-14 エイエフティ ファーマスーティカルズ リミテッド 組み合わせ組成物
IN2014CN02610A (es) * 2011-10-12 2015-08-07 Dow Global Technologies Llc
US20140271783A1 (en) * 2011-10-14 2014-09-18 Purdue Research Foundation Prefabricated pharmaceutical dosage forms from functional polymer films
US10278925B2 (en) * 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
US10105330B2 (en) * 2012-01-04 2018-10-23 Wellesley Pharmaceuticals, Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
US9346742B2 (en) * 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US10792326B2 (en) 2013-06-28 2020-10-06 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for bedwetting and method of use thereof
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
TWI552748B (zh) * 2013-10-25 2016-10-11 The use of a compound for the removal of hepatotoxicity against Acetaminophen (APAP)
TWI666013B (zh) * 2013-10-25 2019-07-21 財團法人國際教育基金會 一種化合物用於去除乙醯胺基酚(Acetaminophen，APAP)藥物肝毒性之用途
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US20150290174A1 (en) * 2014-04-11 2015-10-15 Resuscitate MOE LLC Pharmaceutical formulations and method of using the same for alleviating symptoms of hangover, stomach flu or migraine
US10105328B2 (en) * 2014-06-06 2018-10-23 Wellesley Pharmaceuticals, Llc Composition for reducing frequency of urination, method of making and use thereof
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2017027778A1 (en) * 2015-08-13 2017-02-16 Temple University-Of The Commonwealth System Of Higher Education Calcium alginate dosage formulations, and methods of making and using thereof
CN108135870A (zh) * 2015-09-01 2018-06-08 韦尔斯利医药有限公司 延缓、延迟和立即释放型制剂及其制造方法和用途
WO2019226150A1 (en) * 2018-05-21 2019-11-28 Wellesley Pharmaceuticals Inc. Composition and methods for treating sleep disorders
US20190374474A1 (en) * 2018-06-11 2019-12-12 Wellesley Pharmaceuticals, Llc Pharmaceutical compositions and methods for weight loss
EP3958850A4 (en) * 2019-04-23 2023-04-26 Scisparc Ltd. COMPOSITIONS AND METHODS FOR POTENTIALIZING 4-AMINOPHENOL DERIVATIVES
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
WO2023129946A1 (en) * 2021-12-28 2023-07-06 Zonfrillo Mark Robert Methods and kits for treating fever in children with combined ibuprofen and acetaminophen
CN121285367A (zh) 2023-06-02 2026-01-06 尤利亚·采蒂 包含布洛芬的药物组合物
WO2025042688A2 (en) * 2023-08-18 2025-02-27 R.P. Scherer Technologies, Llc Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen
CN118845609B (zh) * 2024-07-09 2025-04-01 济南舜景医药科技有限公司 一种含有对乙酰氨基酚的栓剂及其制备方法、用途

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
AU528532B2 (en) 1978-12-18 1983-05-05 Mcniel Laboratories Acetaminophen analgesic potentiation
US4543370A (en) * 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
PT77793B (en) 1982-12-09 1986-04-17 Sandoz Sa Process for the preparation of analgesic pharmaceutical compositions containing a combination of 1-(p-chlorobenzlydryl)-4-<2-(2-hydroxyethoxy)-ethyl>-diethylenediamine with one or more non esteroidal antiinflamatory/analgesic agents
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4802924A (en) * 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4966771A (en) * 1987-02-20 1990-10-30 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4820524A (en) 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4867983A (en) * 1987-02-20 1989-09-19 Mcneilab, Inc. Method for double dipping gelating coated caplets
US4851226A (en) 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
DE3822095A1 (de) 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US4984240A (en) * 1988-12-22 1991-01-08 Codex Corporation Distributed switching architecture for communication module redundancy
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5013557A (en) 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5213738A (en) 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
JPH05104315A (ja) * 1991-10-17 1993-04-27 Toyo A Tec Kk シリンダヘツド加工方法及びシリンダヘツド加工用位置決め装置
JP3170855B2 (ja) * 1992-03-03 2001-05-28 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
JP3703481B2 (ja) 1992-01-17 2005-10-05 バーウィンド・ファーマスーティカル・サーヴィスィーズ・インコーポレーテッド セルロース重合体およびラクトースに基づくフィルム被覆および被覆組成物
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
WO1998027931A2 (en) 1996-12-20 1998-07-02 Mcneil-Ppc, Inc. Salts of acetaminophen
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6432442B1 (en) * 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
US20030206942A1 (en) 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6270805B1 (en) * 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6274162B1 (en) * 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR20030019422A (ko) 2000-06-13 2003-03-06 와이어쓰 Ｃｏｘ-２저해제를 함유하는 진통성 및 항-염증성 조성물
AU2001279284A1 (en) 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
US6627212B2 (en) 2001-06-26 2003-09-30 Engelhard Corporation Use of effect pigments in ingested drugs
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
JP2003104903A (ja) 2001-09-28 2003-04-09 Taisho Pharmaceut Co Ltd 鎮咳用組成物
CN1596104A (zh) 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 改进的释放剂型
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
RU2191605C1 (ru) * 2001-10-16 2002-10-27 Нестерук Владимир Викторович Анальгезирующее, спазмолитическое, противовоспалительное лекарственное средство
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
BRPI0512756A (pt) * 2004-07-07 2008-04-08 Aft Pharmaceuticals Ltd composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas

Also Published As

Publication number Publication date
RU2465897C2 (ru) 2012-11-10
JP2010506949A (ja) 2010-03-04
JP5389656B2 (ja) 2014-01-15
EP3292866A1 (en) 2018-03-14
US8580856B2 (en) 2013-11-12
CN101563074A (zh) 2009-10-21
RU2009118960A (ru) 2010-11-27
KR20090094076A (ko) 2009-09-03
AU2007309281B2 (en) 2013-10-31
CA2666582C (en) 2014-09-09
EP3292866B1 (en) 2023-07-26
EP2089013B1 (en) 2017-09-27
EP2089013A1 (en) 2009-08-19
CA2666582A1 (en) 2008-05-02
ES2651444T3 (es) 2018-01-26
CN101563074B (zh) 2012-11-07
US20130150321A1 (en) 2013-06-13
WO2008051759A1 (en) 2008-05-02
AU2007309281A1 (en) 2008-05-02
BRPI0718171A2 (pt) 2013-11-26
US8580855B2 (en) 2013-11-12
US20080103206A1 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
CL2008000510A1 (es) Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero.
PE20081114A1 (es) Composiciones farmaceuticas bioadhesivas de agente dual para uso topico
CL2007001870A1 (es) Composicion farmaceutica de dosificacion solida que comprende valsartan, amlodipina, hidroclorotiazida y aditivos farmaceuticamente aceptables; procedimiento de preparacion; y uso para el tratamiento de hipertension, insuficiencia cardiaca, infarto d
AR067347A1 (es) Combinacion antihelmintica
ECSP003847A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
CL2013000481A1 (es) Metodo y para mejorar la eficacia y/o reducir los efectos secundarios de una farmacoterapia administrada de forma suboptima que comprende la administracion de un hexitol sustituido; composicion farmaceutica; combinacion farmaceutica; uso para tratar enfermedades proliferativas.
DOP2010000387A (es) Compuestos pirazolicos 436
CL2007003609A1 (es) Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
UY30440A1 (es) Nuevos compuestos
ECSP088889A (es) Forma nueva de administración de racecadotril
CL2011002248A1 (es) Composicion farmaceutica oral de liberacion inmediata que comprende oxicodona y naloxona en una proporcion 2:1 en peso; uso de la composicion farmaceutica para tratar dolor intercurrente en paciente que sufren de dolor.
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
CL2013000098A1 (es) Composicion farmaceutica que contienen una formulacion activada y potenciada de un anticuerpo para el receptor canabinoide humano; metodos de uso.
UY31922A (es) Compuestos
CL2008003576A1 (es) Compuestos derivados de amida del acido 6,7-dihidro-5h-imidazo[1,2-alfa]imidazol-3-carboxilico; composicion farmaceutica que los comprende; y usos en el tratamiento de una afeccion inflamatoria.
UY31403A1 (es) &#34;derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos&#34;.
CL2008000610A1 (es) Composicion en forma de dosificacion transdermica o transmucosa que comprende una relacion en peso de buprenorfina a naloxona entre 2,1:1 y 8:1, util para el tratamiento del dolor.
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
AR091039A1 (es) Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
AR044350A1 (es) Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol

Legal Events

Date Code Title Description
FG Grant or registration